- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05330806
Collagenase Chemonucleolysis vs Percutaneous Endoscopic Lumbar Discectomy (PELD) for Lumbar Disc Herniation
March 9, 2023 updated by: Shenzhen People's Hospital
Collagenase Chemonucleolysis vs Percutaneous Endoscopic Lumbar Discectomy (PELD) for Lumbar Disc Herniation, a Randomized Controlled Trial
Lumbar disc herniation compressed the nerve cause pain, numbness, weak legs called sciatica, which seriously decrease the quality of life and work efficiency.
Both collagenase chemonucleolysis(CCNL) and percutaneous endoscopic lumbar discectomy (PELD) was effective to treat lumbar disc herniation(LDH) requires surgery.
whether functional clinical outcomes of CCNL vs PELD effect on LDH was superior, and no study provided convincing evidence.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Lumbar disc herniation (LDH) is a common disease with an incidence of 1%-3%, usually manifested as low back pain radiating to the lower extremities, which seriously affects patients' quality of life.
Collagen hydrolysis was effective in treating LDH, it makes the protrusion smaller or disappeared, relieving or resolving the compression of nerve root by the protrusion.Percutaneous endoscopic lumbar discectomy (PELD) is a less invasive techniques to treat LDH.
However, the outcomes of collagen hydrolysis vs PELD effect was still unknown.
Study Type
Interventional
Enrollment (Anticipated)
140
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hongyu Wang, Doctor
- Phone Number: 18241651300
- Email: wanghongyu790039663@126.com
Study Locations
-
-
Guangdong
-
Shenzhen, Guangdong, China, 518000
- Recruiting
- ShenzhenPH
-
Contact:
- Hongyu Wang, Doctor
- Phone Number: 18241651300
- Email: wanghongyu790039663@126.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- at least six weeks of excessive radiating leg pain with no tendency for any clinical improvement despite conservative therapy
- have a nerve root compression by a lumbar disc herniation proven by magnetic resonance imaging
Exclusion Criteria:
- previous surgery at the same or adjacent disc level;
- isthmic or degenerative spondylolisthesis
- pregnancy
- severe comorbid medical or psychiatric disorder (American Society of Anesthesiologists' classification >2);
- severe caudal or cranial sequestration of disc fragments, defined as sequestration towards more than half of the adjacent vertebra;
- contraindication for surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Collagenase chemonucleolysis
After local anesthesia, and the puncture point was 8-12cm on the side of the paraspinous process under C arm fluoroscopy.
The needle was punctured though the skin with an angle of 45-60 to the posterior of the vertebral via "safe" entry zone to the herniated site outside the intervertebral disc under the epidural space.
The syringe was drawn back to confirm that no blood or cerebrospinal fluid was flowing out, Contrast agents were injected to make sure no flows out of the spinal canal.
600 unit collagenase was dissolved in 2ml normal saline and injected slowly with rate of 1ml per minute.
The needle was removed and keep the dorsal elevated position for 6-8 hours.
Keep away from load bear of lumbar for 3 months.
|
After local anesthesia, and the puncture point was 8-12cm on the side of the paraspinous process under C arm fluoroscopy.
The needle was punctured though the skin with an angle of 45-60 to the posterior of the vertebral via "safe" entry zone to the herniated site outside the intervertebral disc under the epidural space.
The syringe was drawn back to confirm that no blood or cerebrospinal fluid was flowing out, Contrast agents were injected to make sure no flows out of the spinal canal.
600 unit collagenase was dissolved in 2ml normal saline and injected slowly with rate of 1ml per minute.
The needle was removed and keep the dorsal elevated position for 6-8 hours.
Keep away from load bear of lumbar for 3 months.
|
|
Active Comparator: Percutaneous endoscopic lumbar discectomy (PELD)
For L1-L4 segment, percutaneous endoscopic transforaminal discectomy(PETD) will be performed.
An 1cm length incision was made at 8-14cm lateral of the paraspinous process, where a needle puncture to the superior articular process of the lower involved vertebrae of the herniated disc.
A series of conical rods are to be introduced, subsequently a reamer is to be introduced through the cannula.
After removal of the disc herniation, the cannula and endoscope are to be removed.
For L5/S1 segment, percutaneous endoscopic interlaminar discectomy(PEID) was performed.
An incision of nearly 7 mm was made at the entry point of the skin, and a series of expansion channels were sequentially inserted into the surface of the ligamentum flavum.Then, the ligamentum flavum and soft tissue around it were removed.
Then, the tongue of the working cannula was inserted and rotated into the lateral nerve root.
Removed the prominent nucleus pulposus by various nucleus pulposus forceps.
|
For L1-L4 segment, percutaneous endoscopic transforaminal discectomy(PETD) will be performed.
An 1cm length incision was made at 8-14cm lateral of the paraspinous process, where a needle puncture to the superior articular process of the lower involved vertebrae of the herniated disc.
A series of conical rods are to be introduced, subsequently a reamer is to be introduced through the cannula.
After removal of the disc herniation, the cannula and endoscope are to be removed.
For L5/S1 segment, percutaneous endoscopic interlaminar discectomy(PEID) was performed.
An incision of nearly 7 mm was made at the entry point of the skin, and a series of expansion channels were sequentially inserted into the surface of the ligamentum flavum.Then, the ligamentum flavum and soft tissue around it were removed.
Then, the tongue of the working cannula was inserted and rotated into the lateral nerve root.
Removed the prominent nucleus pulposus by various nucleus pulposus forceps.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analogue Scale/Score of leg
Time Frame: up to 12 months
|
Visual Analogue Scale pain assess for leg.
Use a ruler about 10cm long, one side is marked with "0" and the other "10" respectively.
A score of 0 indicates no pain, 10 indicates the most unbearable pain.
|
up to 12 months
|
|
Visual Analogue Scale/Score of lumbar
Time Frame: up to 12 months
|
Visual Analogue Scale pain assess for lumbar.
Use a ruler about 10cm long, one side is marked with "0" and the other "10" respectively.
A score of 0 indicates no pain, 10 indicates the most unbearable pain.
|
up to 12 months
|
|
reoperation
Time Frame: up to 12 months
|
The percentage of reoperation rate.
0 represents the minimum and 100% represents the maximum.
|
up to 12 months
|
|
Recurrence rate
Time Frame: up to 12 months
|
The percentage of disc herniation recurrence appearance.
0 represents the minimum and 100% represents the maximum.
|
up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Roland-Morris Disability Questionnaire
Time Frame: up to 12 month
|
The Roland-Morris Disability Questionnaire is a health status measure designed to be completed by patients to assess physical disability due to low back pain.
The lowest score is 0, the highest 24.
The higher the score, the more severe the dysfunction.
|
up to 12 month
|
|
Duration of operation
Time Frame: up to 12 month
|
Duration of operation time: The minimum value is 1 minute, and the maximum value is 120 minutes
|
up to 12 month
|
|
Length of stay in the hospital
Time Frame: up to 12 month
|
Length of stay in the hospital: The minimum value is 1 day.
The maximum value is 30 days
|
up to 12 month
|
|
Major complications
Time Frame: up to 12 month
|
Major complications includes cerebrospinal fluid leakage,deep venous thrombosis in the leg, transient increase in neurological deficit, repeated surgery,Opioid analgesics
|
up to 12 month
|
|
hospital fees
Time Frame: up to 12 month
|
hospital fees :Minimum 500 yuan, maximum 30,000 yuan
|
up to 12 month
|
|
the EuroQoL-5D (EQ-5D)
Time Frame: up to 12 month
|
EQ-5D descriptive system is a preference-based Health-related quality of life measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
From this, a quality of life score can be calculated ranging from -0.594, indicating a health state worse than death where 0 is death, to 1, indicating full health
|
up to 12 month
|
|
the Oswestry Disability Index (ODI)
Time Frame: up to 12 month
|
Disability was evaluated using the Oswestry Disability Index (ODI)
|
up to 12 month
|
|
the Medical Outcomes Study 12-item short-form health survey (SF-12) scale
Time Frame: up to 12 month
|
SF-12 including mental and physical components, was shorter versions of 36-item Short-Form Health Survey (SF-36) to evaluate life quality
|
up to 12 month
|
|
cost-effectiveness
Time Frame: up to 12 month
|
Incremental cost-effectiveness ratios (ICERs) will be calculated by dividing the difference in costs by the difference in effects.
|
up to 12 month
|
|
modified MacNab
Time Frame: up to 12 month
|
modified MacNab criteria is patient satisfaction with excellent outcomes, good, fair, and poor.
|
up to 12 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Songlin Peng, Doctor, Shenzhen People's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gibson JN, Cowie JG, Iprenburg M. Transforaminal endoscopic spinal surgery: the future 'gold standard' for discectomy? - A review. Surgeon. 2012 Oct;10(5):290-6. doi: 10.1016/j.surge.2012.05.001. Epub 2012 Jun 15.
- Yuan P, Shi X, Wei X, Wang Z, Mu J, Zhang H. Development process and clinical application of collagenase chemonucleolysis in the treatment of lumbar disc herniation: a narrative review in China. Postgrad Med J. 2022 Mar 14:postgradmedj-2021-141208. doi: 10.1136/postgradmedj-2021-141208. Online ahead of print.
- Gadjradj PS, Harhangi BS. Percutaneous Transforaminal Endoscopic Discectomy for Lumbar Disk Herniation. Clin Spine Surg. 2016 Nov;29(9):368-371. doi: 10.1097/BSD.0000000000000366.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2021
Primary Completion (Anticipated)
June 25, 2023
Study Completion (Anticipated)
June 28, 2023
Study Registration Dates
First Submitted
March 24, 2022
First Submitted That Met QC Criteria
April 14, 2022
First Posted (Actual)
April 15, 2022
Study Record Updates
Last Update Posted (Estimate)
March 10, 2023
Last Update Submitted That Met QC Criteria
March 9, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ShenzhenPH spine wang05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Disc Herniation
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingLumbar Disc Herniation | Lumbar Disc DegenerationChina
-
Shin Kong Wu Ho-Su Memorial HospitalTerminatedLumbar Disc Herniation | Lumbar Traction | Spinal Manipulation | Lumbar SurgeryTaiwan
-
Intrinsic TherapeuticsActive, not recruitingLumbar Disc Herniation | Annular Disc Tear | Annular Tear of Lumbar DiscBelgium, Germany
-
Medtronic Spinal and BiologicsCompletedDegenerative Disc Disease, Lumbar | Disc Herniation, LumbarCzech Republic, Slovakia, Venezuela
-
Akdeniz UniversityCompletedLumbar Disc Herniation | Lumbar Spine SurgeryTurkey
-
Allina Health SystemTwin Cities Spine CenterSuspendedLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Disc DiseaseUnited States
-
Firat UniversityRecruiting
-
Ramathibodi HospitalNot yet recruitingLumbar Disc Herniation
-
Zhou XingchenCompletedLumbar Disc HerniationChina
-
Centre Hospitalier Universitaire de NiceCompleted
Clinical Trials on Collagenase chemonucleolysis
-
Stony Brook UniversityCompletedAdhesion of Flexor Tendon of HandUnited States
-
Azidus BrasilSuspended
-
HealthpointCompleted
-
Stony Brook UniversityWithdrawnAdhesive Capsulitis | Frozen ShoulderUnited States
-
State University of New YorkCompletedDupuytren's Contracture
-
State University of New YorkCompletedDupuytren's ContractureUnited States
-
Sheba Medical CenterUnknown
-
National Taiwan University HospitalUnknownAlkaline Chemical Burn Of Cornea And Conjunctival Sac | Acid Chemical Burn Of Cornea And Conjunctival Sac | Benign Mucous Membrane Pemphigoid With Ocular InvolvementTaiwan
-
University Hospital, GhentTerminatedEsophageal Stricture | Stricture | Anastomotic | CollagenosisBelgium
-
Endo PharmaceuticalsCompletedEdematous SkinUnited States